Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Amplitude Appoints OpenAI's CTO of Applications to Board

Amplitude named Vijaye Raji, the founder of Statsig and now OpenAI’s CTO of Applications, to its board of directors as the company folds Statsig more tightly into its platform.

Raji launched Statsig in 2021 and built it around experimentation and measurement tools. The company said Statsig’s platform will continue operating under its own brand inside Amplitude, preserving the mission to make data tools more accessible to product teams.

Amplitude said the combined Amplitude-Statsig effort is aimed at helping teams understand customer behavior, run experiments, and build products with more confidence. The move comes as the company positions experimentation as a bigger part of its offering.

Raji’s background includes work at Microsoft on developer tools and software platforms. At OpenAI, he leads Ads, Growth, and core data and engineering functions.

Amplitude also highlighted its customer base, saying it serves more than 5,200 customers, including Atlassian, Replit, The Economist and Square. As a result of these announcements, the company's shares have moved 3.53% on the market, and are now trading at a price of $15.83. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS